UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 29

Sortiert nach

Predictors of Radiation Pneumonitis in Patients Receiving Intensity Modulated Radiation Therapy for Hodgkin and Non-Hodgkin Lymphoma

International journal of radiation oncology, biology, physics, 2015-05, Vol.92 (1), p.175-182

2015

Link zum Volltext

Verfügbarkeit prüfen

Improvement of Overall and Failure-Free Survival in Stage IV Follicular Lymphoma: 25 Years of Treatment Experience at The University of Texas M.D. Anderson Cancer Center

Journal of clinical oncology, 2006-04, Vol.24 (10), p.1582-1589

2006

Link zum Volltext

Verfügbarkeit prüfen

The Absolute Monocyte and Lymphocyte Prognostic Index for Patients With Diffuse Large B-Cell Lymphoma Who Receive R-CHOP

Clinical lymphoma, myeloma and leukemia, 2013-02, Vol.13 (1), p.15-18

2013

Link zum Volltext

Verfügbarkeit prüfen

Phase II Study of Denileukin Diftitox for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

Journal of clinical oncology, 2004-10, Vol.22 (20), p.4095-4102

2004

Link zum Volltext

Verfügbarkeit prüfen

Ibrutinib–rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial

The lancet oncology, 2022-03, Vol.23 (3), p.406-415

2022

Link zum Volltext

Verfügbarkeit prüfen

Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up

Blood cancer journal (New York), 2020-05, Vol.10 (5), p.49-49, Article 49

2020

Link zum Volltext

Verfügbarkeit prüfen

Clinical implications of positron emission tomography-negative residual computed tomography masses after chemotherapy for diffuse large B-cell lymphoma

Leukemia & lymphoma, 2013-12, Vol.54 (12), p.2631-2638

2013

Link zum Volltext

Verfügbarkeit prüfen

Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomas

Leukemia & lymphoma, 2012-01, Vol.53 (1), p.50-56

2012

Link zum Volltext

Verfügbarkeit prüfen

Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial

Clinical lymphoma, myeloma and leukemia, 2013-04, Vol.13 (2), p.99-105

2013

Link zum Volltext

Verfügbarkeit prüfen

Hodgkin's lymphoma in younger patients: lessons learned on the road to success

Oncology (Williston Park, N.Y.), 2007-04, Vol.21 (4), p.434

Hagemeister, Fredrick B

2007

Link zum Volltext

Verfügbarkeit prüfen

Doxorubicin, bleomycin, vinblastine and dacarbazine chemotherapy with interferon for advanced stage classic Hodgkin lymphoma: a 10-year follow-up study

Leukemia & lymphoma, 2012-05, Vol.53 (5), p.801-806

2012

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of oxaliplatin in patients with recurrent or refractory non‐Hodgkin lymphoma

Cancer, 2005-08, Vol.104 (4), p.781-787

2005

Link zum Volltext

Verfügbarkeit prüfen

NOVP chemotherapy for Hodgkin's disease transiently induces sperm aneuploidies associated with the major clinical aneuploidy syndromes involving chromosomes X, y, 18, and 21

Cancer research (Chicago, Ill.), 2003, Vol.63 (1), p.44-51

2003

Link zum Volltext

Verfügbarkeit prüfen

Thalidomide for patients with recurrent lymphoma

Cancer, 2004-03, Vol.100 (6), p.1186-1189

2004

Link zum Volltext

Verfügbarkeit prüfen

Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen

Cancer, 2005-07, Vol.104 (2), p.345-353

2005

Link zum Volltext

Verfügbarkeit prüfen

Pegfilgrastim administered in a single fixed dose is effective in inducing neutrophil count recovery after paclitaxel and topotecan chemotherapy in patients with relapsed aggressive non-Hodgkin's lymphoma

Leukemia & lymphoma, 2006-03, Vol.47 (3), p.481-485

2006

Link zum Volltext

Verfügbarkeit prüfen

Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphoma

Leukemia & lymphoma, 2006-09, Vol.47 (9), p.1818-1821

2006

Link zum Volltext

Verfügbarkeit prüfen

Pentostatin in T-non-Hodgkin's lymphomas: efficacy and effect on CD26+ T lymphocytes

Oncology reports, 2003-09, Vol.10 (5), p.1513

2003

Link zum Volltext

Verfügbarkeit prüfen

Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/mesna for patients with relapsed or refractory non-Hodgkin's lymphoma after failure to cytarabine/cisplatin combination

Investigational new drugs, 1999-05, Vol.17 (2), p.187-192

1999

Link zum Volltext

Verfügbarkeit prüfen

Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma

Journal of clinical oncology, 1992-05, Vol.10 (5), p.790-794

1992

Link zum Volltext

Verfügbarkeit prüfen

No effect of 96-hour paclitaxel infusion in patients with relapsed non-Hodgkin's lymphoma refractory to a 3-hour infusion schedule

Journal of clinical oncology, 1996-02, Vol.14 (2), p.543-548

1996

Link zum Volltext

Verfügbarkeit prüfen

Small noncleaved cell lymphoma in adults: superior results for stages I-III disease

Journal of clinical oncology, 1990-04, Vol.8 (4), p.615-622

1990

Link zum Volltext

Verfügbarkeit prüfen

Hodgkin's disease : Correlation of clinical characteristics with probabilities for negative lymphangiogram vs. negative laparotomy findings in patients with stage I supradiaphragmatic presentations vs. those in patients with stage II

International journal of radiation oncology, biology, physics, 1998-01, Vol.40 (2), p.377-386

1998

Link zum Volltext

Verfügbarkeit prüfen

Phase I Study of Fludarabine and Paclitaxel for the Treatment of Low-Grade Non-Hodgkin's Lymphoma

Leukemia & lymphoma, 1997, Vol.26 (1-2), p.77-82

1997

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 29

Suche als RSS-Feed

Aktive Filter

ThemaCombined Modality Therapy

ThemaAdult

ThemaOncology

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(28)
Mit Volltextzugriff
(28)

Publikationsform

Artikel
(29)

Sprache

Englisch
(29)
Japanisch
(2)

Erscheinungsjahr

n.n

Thema

Humans
(29)
Life Sciences & Biomedicine
(29)
Science & Technology
(29)
Middle Aged
(24)
Male
(23)
Female
(22)
Aged
(21)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(17)
Treatment Outcome
(14)
Biological And Medical Sciences
(13)
Medical Sciences
(13)
Hematology
(12)
Lymphoma, Non-Hodgkin - Drug Therapy
(11)
Neoplasm Staging
(9)
Prognosis
(9)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(8)
Hodgkin Disease - Drug Therapy
(8)
Chemotherapy
(7)

13 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Predictors of Radiation Pneumonitis in Patients Receiving Intensity Modulated Radiation Therapy for Hodgkin and Non-Hodgkin Lymphoma

Improvement of Overall and Failure-Free Survival in Stage IV Follicular Lymphoma: 25 Years of Treatment Experience at The University of Texas M.D. Anderson Cancer Center

The Absolute Monocyte and Lymphocyte Prognostic Index for Patients With Diffuse Large B-Cell Lymphoma Who Receive R-CHOP

Safety and activity of lenalidomide and rituximab in untreated indolent lymphoma: an open-label, phase 2 trial

Phase II Study of Denileukin Diftitox for Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma

Ibrutinib–rituximab followed by R-HCVAD as frontline treatment for young patients (≤65 years) with mantle cell lymphoma (WINDOW-1): a single-arm, phase 2 trial

Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up

Clinical implications of positron emission tomography-negative residual computed tomography masses after chemotherapy for diffuse large B-cell lymphoma

Prognostic value of serum CD44, intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 levels in patients with indolent non-Hodgkin lymphomas

Zoledronic Acid for Prevention of Bone Loss in Patients Receiving Primary Therapy for Lymphomas: A Prospective, Randomized Controlled Phase III Trial

Hodgkin's lymphoma in younger patients: lessons learned on the road to success

Doxorubicin, bleomycin, vinblastine and dacarbazine chemotherapy with interferon for advanced stage classic Hodgkin lymphoma: a 10-year follow-up study

Phase II study of oxaliplatin in patients with recurrent or refractory non‐Hodgkin lymphoma

NOVP chemotherapy for Hodgkin's disease transiently induces sperm aneuploidies associated with the major clinical aneuploidy syndromes involving chromosomes X, y, 18, and 21

Thalidomide for patients with recurrent lymphoma

Immunosuppression and infectious complications in patients with stage IV indolent lymphoma treated with a fludarabine, mitoxantrone, and dexamethasone regimen

Pegfilgrastim administered in a single fixed dose is effective in inducing neutrophil count recovery after paclitaxel and topotecan chemotherapy in patients with relapsed aggressive non-Hodgkin's lymphoma

Phase 2 study of fludarabine and paclitaxel in patients with recurrent low-grade non-Hodgkin's lymphoma

Pentostatin in T-non-Hodgkin's lymphomas: efficacy and effect on CD26+ T lymphocytes

Phase II study of paclitaxel in combination with mitoxantrone and ifosfamide/mesna for patients with relapsed or refractory non-Hodgkin's lymphoma after failure to cytarabine/cisplatin combination

Phase II trial of fludarabine phosphate in lymphoma: an effective new agent in low-grade lymphoma

No effect of 96-hour paclitaxel infusion in patients with relapsed non-Hodgkin's lymphoma refractory to a 3-hour infusion schedule

Small noncleaved cell lymphoma in adults: superior results for stages I-III disease

Hodgkin's disease : Correlation of clinical characteristics with probabilities for negative lymphangiogram vs. negative laparotomy findings in patients with stage I supradiaphragmatic presentations vs. those in patients with stage II

Phase I Study of Fludarabine and Paclitaxel for the Treatment of Low-Grade Non-Hodgkin's Lymphoma

Aktive Filter

Suchergebnisse filtern